Gastric acid secretion: Changes during a century

Best Practice and Research: Clinical Gastroenterology

Volumn 28, Issue 6, 2014, Pages 953-965

  Di Mario, Francesco ^a   Goni, Elisabetta ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Acid regulatory drugs; Chronic atrophic gastritis; Dyspepsia; Gastric acid secretion; Gastric cancer risk; Gastric physiology; GERD; Helicobacter pylori infection; Peptic ulcer disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; HYDROCHLORIC ACID; PEPSINOGEN; PROTON PUMP INHIBITOR;

ARTICLE; ASPIRATION; ENVIRONMENTAL FACTOR; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HUMAN; MEASUREMENT; MUCOSA; MUCOUS CELL; MULTIPOTENT STEM CELL; PATHOPHYSIOLOGY; PEPTIC ULCER; STOMACH; STOMACH ACID; STOMACH ACID SECRETION; STOMACH CANCER; STOMACH FUNCTION; STOMACH PARIETAL CELL; TITRIMETRY; GASTROINTESTINAL DISEASE; HELICOBACTER PYLORI; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PHYSIOLOGY; SECRETION (PROCESS);

GASTRIC ACID; GASTROINTESTINAL DISEASES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; STOMACH;

EID: 84925221821     PISSN: 15216918     EISSN: 15321916     Source Type: Journal    
DOI: 10.1016/j.bpg.2014.10.006     Document Type: Review

References (95)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;323: 1311-5.
2. Johnson S. The ghost map: The story of London's most terrifying epidemic - and how it changed science, cities, and the modern world. London: Penguin Books; 2006.
3. Lancaster HO. Deafness as an epidemic disease in Australia; a note on census and institutional data. Br Med J 1951;2: 1429-32.
4. Atuhaire LK, Campbell MJ, Cochrane AL, Jones M, Moore F. Gastric cancer in a south Wales valley. Br J Ind Med 1986;43: 497-9.
5. Sonnenberg A, Sonnenberg GS. Epidemiology of ulcer disease. In: Domschke W, Konturek SJ, editors. The stomach: Physiology, pathophysiology and treatment. Berlin: Springer Verlag; 1993. p. 215-27.
6. MacMahon B, Pugh TF. Epidemiology - principles and methods. Boston: Little, Brown and Company; 1970. p. 157-206.
7. Shiotani A, Graham DY. Pathogenesis and therapy of gastric and duodenal ulcer disease. Med Clin North Am 2002;86: 1447-66.
8. Veldhuyzen van Zanten SJ, Pollak PT, Best LM, Bezanson GS, Marrie T. Increasing prevalence of Helicobacter pylori infection with age: Continuous risk of infection in adults rather than cohort effect. J Infect Dis 1994;169: 434-7.
9. Spicer CC, Stewart DN, Der Winser DM. Perforated peptic ulcer during the period of heavy air-raids. Lancet 1944;1: 14.
10. Aoyama N, Kinoshita Y, Fujimoto S, Himeno S, Todo A, Kasuga M, et al. Peptic ulcers after the Hanshin-Awaji earthquake: Increased incidence of bleeding gastric ulcers. Am J Gastroenterol 1998;93: 311-6.
11. Graham DY. Helicobacter pylori: Its epidemiology and its role in duodenal ulcer disease. J Gastroenterol Hepatol 1991;6: 105-13.
12. Banatvala N, Mayo K, Megraud F, Jennings R, Deeks JJ, Feldman RA. The cohort effect and Helicobacter pylori. J Infect Dis 1993;168: 219-21.
13. Linz B, Balloux F, Moodley Y, Manica A, Liu H, Roumagnac P, et al. An African origin for the intimate association between humans and Helicobacter pylori. Nature 2007;445: 915-8.
14. Sonnenberg A. Review article: Historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther 2013; 38: 329-42.
15. Baron JH. Peptic ulcer. Mt Sinai J Med 2000;67: 58-62.
16. Jennings D. Perforated peptic ulcer. Changes in age-incidence and sexdistribution in the last 150 years. Lancet 1940;1: 395-8. 444-7.
17. Brinton W. On the pathology, symptoms and treatment of ulcer of the stomach. London: John Churchill; 1857 (Facsimile published by Oxford Historical Books, Abingdon 1990).
18. Baron JH, Sonnenberg A. Hospital admissions for peptic ulcer and indigestion in London and New York in the 19th and early 20th centuries. Gut 2002;50: 568-70.
19. Baron JH, Watson F, Sonnenberg A. Three centuries of stomach symptoms in Scotland. Aliment Pharmacol Ther 2006;24: 821-9.
20. Baron JH, Sonnenberg A. Early history of dyspepsia and peptic ulcer in the United States. Am J Gastroenterol 2009;104: 2893-6.
21. Baron JH, Sonnenberg A. Publications on peptic ulcer in Britain, France, Germany and the US. Eur J Gastroenterol Hepatol 2002;14: 711-5.
22. Vogt TM, Johnson RE. Recent changes in the incidence of duodenal and gastric ulcer. Am J Epidemiol 1980;111: 713-20.
23. Fineberg HV, Pearlman LA. Surgical treatment of peptic ulcer in the United States. Trends before and after the introduction of cimetidine. Lancet 1981;1: 1305-7.
24. O'Connor PC, Griffiths K, Shanks RG. Trends in peptic ulcer related diseases from 1972 to 1980. Hospital activity analysis data and general practice cimetidine prescribing levels. Eur J Clin Pharmacol 1980;1983: 435-40.
25. Gustavsson S, Kelly KA, Melton LJ, Zinsmeister AR. Trends in peptic ulcer surgery. A population-based study in Rochester, Minnesota, 1956-1985. Gastroenterology 1988;94: 688-94.
26. Sonnenberg A. Birth-cohort patterns of mortality from ulcerative colitis and peptic ulcer. AEP 2008;18: 813-9.
27. Baron JH et al. Publications on peptic ulcer in Britain, France, Germany and the US. Eur J Gastroenterol Hepatol 14: 711-715.
28. Sonnenberg A. Esophageal diseases. US Government Printing Office. In: Everhart JE, editor. Digestive diseases in the United States: Epidemiology and impact. Washington, DC: US Department of Health and Human Services; 1994. p. 299-356. NIH publication no. 94-1447.
29. El-Serag HB, Sonnenberg A. Opposing time trends of peptic ulcer and reflux disease. Gut 1998;43: 327-33.
30. El-Serag HB. Time trends of gastroesophageal reflux disease: A systematic review. Clin Gastroenterol Hepatol 2007;5: 17-26.
31. El-Serag HB. The epidemic of esophageal adenocarcinoma. Gastroenterol Clin North Am 2002;31: 421-40.
32. Raghunath A, Hungin AP, Wooff D, Childs S. Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: Systematic review. BMJ 2003;326: 737-44.
33. Sharma P, Vakil N. Review article: Helicobacter pylori and reflux disease. Aliment Pharmacol Ther 2003;17: 297-305.
34. Delaney B, McColl K. Review article: Helicobacter pylori and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;22: 32-40.
35. Wang C, Yuan Y, Hunt RH. Helicobacter pylori infection and Barrett's esophagus: A systematic review and meta-analysis. Am J Gastroenterol 2009;104: 492-500.
36. Islami F, Kamangar F. Helicobacter pylori and esophageal cancer risk: A meta-analysis. Cancer Prev Res 2008;1: 329-38.
37. Pohl H, Wrobel K, Bojarski C, VoderholzerW, Sonnenberg A, Rösch T, et al. Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol 2013;108: 200-7.
38. Hampel H, Abraham NS, El-Serag HB. Meta-analysis: Obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 2005;143: 199-211.
39. Corley DA, Kubo A. Body mass index and gastroesophageal reflux disease: A systematic review and meta-analysis. Am J Gastroenterol 2006;101: 2619-28.
40. Friedenberg FK, Xanthopoulos M, Foster GD, Richter JE. The association between gastroesophageal reflux disease and obesity. Am J Gastroenterol 2008;103: 2111-22.
41. Chandrasoma P. Controversies of the cardiac mucosa and Barrett's oesophagus. Histopathology 2005;46: 361-73.
42. Schubert ML, Peura DA. Control of gastric acid secretion in health and disease. Gastroenterology 2008;134: 1842-60.
43. Hoffmann W. Regeneration of the gastric mucosa and its glands from stem cells. Curr Med Chem 2008;15: 3133-44.
44. Karam SM. A focus on parietal cells as a renewing cell population. World J Gastroenterol 2010;16: 538-46.
45. Zavros Y, Orr MA, Xiao C, Malinowska DH. Sonic hedgehog is associated with H+-K+-ATPase-containing membranes in gastric parietal cells and secreted with histamine stimulation. Am J Physiol Gastrointest Liver Physiol 2008;295: G99-111.
46. Mix H, Widjaja A, Jandl O, Cornberg M, Kaul A, Göke M, et al. Expression of leptin and leptin receptor isoforms in the human stomach. Gut 2000;47: 481-6.
47. Bado A, Levasseur S, Attoub S, Kermorgant S, Laigneau JP, Bortoluzzi MN, et al. The stomach is a source of leptin. Nature 1998;394: 790-3.
48. Gower WR, Premaratne S, McCuen RW, Arimura A, McAfee Q, Schubert ML. Gastric atrial natriuretic peptide regulates endocrine secretion in antrum and fundus of human and rat stomach. Am J Physiol Gastrointest Liver Physiol 2003;284: G638-45.
49. Hirsch AB, McCuen RW, Arimura A, Schubert ML. Adrenomedullin stimulates somatostatin and thus inhibits histamine and acid secretion in the fundus of the stomach. Regul Pep 2003;110: 189-95.
50. Prinz C, Kajimura M, Scott DR, Mercier F, Helander HF, Sachs G. Histamine secretion from rat enterochromaffinlike cells. Gastroenterology 1993;105: 449-61.
51. Chen D, Zhao CM, Lindström E, Håkanson R. Rat stomach ECL cells up-date of biology and physiology. Gen Pharmacol 1999;32: 413-22.
52. Zaki M, Koduru S, McCuen R, Vuyyuru L, Schubert ML. Amylin, released from the gastric fundus, stimulates somatostatin and thus inhibits histamine and acid secretion in mice. Gastroenterology 2002;123: 247-55.
53. Larsson LI, Goltermann N, de Magistris L, Rehfeld JF, Schwartz TW. Somatostatin cell processes as pathways for paracrine secretion. Science 1979;205: 1393-5.
54. Zhao CM, Furnes MW, Stenström B, Kulseng B, Chen D. Characterization of obestatin-and ghrelin-producing cells in the gastrointestinal tract and pancreas of rats: An immunohistochemical and electron-microscopic study. Cell Tissue Res 2008;331: 575-87.
55. Mizutani M, Atsuchi K, Asakawa A, Matsuda N, FujimuraM, Inui A, et al. Localization of acyl ghrelin-and des-acyl ghrelinimmunoreactive cells in the rat stomach and their responses to intragastric pH. Am J Physiol Gastrointest Liver Physiol 2009;297: G874-980.
56. Bordi C, D'Adda T, Azzoni C, Ferraro G. Classification of gastric endocrine cells at the light and electron microscopical levels. Microsc Res Tech 2000;48: 258-71.
57. Schubert ML, Edwards NF, Arimura A, Makhlouf GM. Paracrine regulation of gastric acid secretion by fundic somatostatin. Am J Physiol Gastrointest Liver Physiol 1987;252: G485-90.
58. Schubert ML. Linkage between somatostatin and acid secretion: Evidence from use of pertussis toxin. Am J Physiol Gastrointest Liver Physiol 1989;256: G418-22.
59. Makhlouf GM, Schubert ML. Gastric somatostatin: A paracrine regulator of acid secretion. Metabolism 1990;39: 138-42.
60. Saffouri B, Weir GC, Bitar KN, Makhlouf GM. Stimulation of gastrin secretion from the perfused rat stomach by somatostatin antiserum. Life Sci 1979;25: 1749-54.
61. Dranoff JA, Ogawa M, Kruglov EA, Gaça MD, Sévigny J, Robson SC, et al. Expression of P2Y nucleotide receptors and ectonucleotidases in quiescent and activated rat hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol 1994;266: G417-24.
62. Holst JJ, Jorgensen PN, Rasmussen TN. Somatostatin restraint of gastrin secretion in pigs revealed by monoclonal antibody immunoneutralization. Am J Physiol Gastrointest Liver Physiol 1992;263: G908-12.
63. Short GM, Doyle JW, Wolfe MM. Effect of antibodies to somatostatin on acid secretion and gastrin release by the isolated perfused rat stomach. Gastroenterology 1985;88: 984-8.
64. Johansson M, Synnerstad I, Holm L. Acid transport through channels in the mucous layer of rat stomach. Gastroenterology 2000;119: 1297-304.
65. Wilkes JM, Kajimura M, Scott DR, Hersey SJ, Sachs G. Muscarinic responses of gastric parietal cells. J Membr Biol 1991; 122: 97-110.
66. Chew CS, Brown MR. Release of intracellular Ca2+ and elevation of inositol trisphosphate by secretagogues in parietal and chief cells isolated from rabbit gastric mucosa. Biochim Biophys Acta 1986;888: 116-25.
67. Wang L, Gantz I, DelValle J. Histamine H2 receptor activates adenylate cyclase and PLC via separate GTP-dependent pathways. Am J Physiol Gastrointest Liver Physiol 1996;271: G613-20.
68. Okuda S, Honda M, Ito Y, Aihara E, Kato S, Mitsufuji S, et al. Phosphodiesterase isozymes involved in regulating acid secretion in the isolated mouse stomach. J Physiol Pharmacol 2009;60: 183-90.
69. Rotte A, Pasham V, Bhandaru M, Eichenmüller M, Yang W, Qadri SM, et al. Regulation of gastric acid secretion by PKB/Akt2. Cell Physiol Biochem 2010;25: 695-704.
70. Physiology of the Gastrointestinal Tract, 5th ed. Leonard R. Johnson, Fayez K. Ghishan, Jonathan D. Kaunitz, Juanita L. Merchant, Hamid M. Said, and Jackie D. Wood Chapter 47, 1281-1309
71. Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, et al. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006;55: 158-64.
72. McColl KE, El-Omar E. How does H. pylori infection cause gastric cancer? Keio J Med 2002;51(Suppl. 2): 53-6.
73. Kim Barrett. Gastrointestinal physiology, Lange Medical Books, Mc Graw Hill Company, 2nd ed.
74. Moore EW, Scarlata RW. The determination of gastric acidity by the glass electrode. Gastroenterology 1965;49: 178-88.
75. Klein KB. Gastric secretory testing. In: Drossman DA, editor. Manual of gastroenterologic procedures. New York: Raven Press; 1993. p. 61-7.
76. Dalenbäck J, Fändriks L, Olbe L. Mechanisms behind changes in gastric acid and bicarbonate outputs during the human interdigestive motility cycle. Am J Physiol Gastrointest Liver Physiol 1996;270: G113-22.
77. Gardner JD, Ciociola AA, Robinson M. Measurement of meal-stimulated gastric acid secretion by in vivo gastric autotitration. J Appl Physiol 2002;92: 427-34.
78. Fordtran JS, Walsh JH. Gastric acid secretion rate and buffer content of the stomach after eating. Results in normal subjects and in patients with duodenal ulcer. J Clin Invest 1973;72: 645-57.
79. Ayazi S, Leers JM, Oezcelik A, Abate E, Peyre CG, Hagen JA, et al. Measurement of gastric pH in ambulatory esophageal pH monitoring. Surg Endosc 2009;23: 1968-73.
80. Hasler WL, Coleski R, CheyWD. Differences in intragastric pH in diabetic vs. idiopathic gastroparesis: Relation to degree of gastric retention. Am J Physiol Gastrointest Liver Physiol 2008;294: G1384-91.
81. Giouvanoudi AC, Spyrou NM. Epigastric electrical impedance for the quantitative determination of the gastric acidity. Physiol Meas 2008;29: 1305-17.
82. Clough MR, Axon AT. The Calcium Carbonate Breath Test, a noninvasive test of stimulated gastric acid secretion: Preliminary communication. Eur J Gastroenterol Hepatol 2009;21: 266-72.
83. Tóth E, Sjölund K, Thorsson O, Thorlacius H. Evaluation of gastric acid secretion at endoscopy with a modified Congo red test. Gastrointest Endosc 2002;56: 254-9.
84. Sipponen P, Härkönen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Clin Lab 2002;48: 505-15 [Review].
85. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, et al. Management of Helicobacter pylori infectionethe maastricht IV/Florence consensus report. Gut 2012;61: 646-64.
86. Miki K, Ichinose M, Ishikawa KB, Yahagi N, Matsushima M, Kakei N, et al. Clinical application of serum pepsinogen I and II levels for mass screening to detect gastric cancer. Jpn J Cancer Res 1993;84: 1086-90.
87. Yanaoka K, Oka M, Ohata H, Yoshimura N, Deguchi H, Mukoubayashi C, et al. Eradication of Helicobacter pylori prevents cancer development in subjects with mild gastric atrophy identified by serum pepsinogen levels. Int J Cancer 2009;125. 2697-2703.
88. Modlin IM, Sachs G, Wright N, Kidd M. Edkins and a century of acid suppression. Digestion 2005;72: 129-45.
89. Scarpignato C, Pelosini I, Di Mario F. Acid suppression therapy: Where do we go from here? Dig Dis 2005;24: 7-42.
90. Tytgat GN. Are there unmet needs in acid suppression? Best Pract Res Clin Gastroenterol 2004;18: 67-72.
91. Hunt RH. Review article: The unmet needs in delayed-release proton-pump inhibitor therapy in 2005. Aliment Pharmacol Ther 2005;22(Suppl. 3): 10-9.
92. Yuan Y, Wang CC, Yuan Y-H, Hunt RH. The proportion of patients who are free of reflux symptoms during the initial days of treatment with proton pump inhibitors (PPIs) in GERD trials: A meta-analysis. Gastroenterology 2008;134(Suppl. 1): A-174.
93. Katz PO, Scheiman JM, Barkun AN. Review article: Acid-related disease-what are the unmet clinical needs? Aliment Pharmacol Ther 2006;23(Suppl. 2): 9-22.
94. Scarpignato C, Hunt RH. Proton pump inhibitors: The beginning of the end or the end of the beginning? Curr Opin Pharmacol 2008;8: 677-84.
95. Attumi TA, Graham DY. High-dose extended-release lansoprazole (dexlansoprazole) and amoxicillin dual therapy for Helicobacter pylori infections. Helicobacter 2014;19: 319-22.